CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors

preview_player
Показать описание
CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors
Dr. Dimitrios L. Wagner
Head of R&D, Berlin Center for Advanced Therapies (BeCAT)
  1. GenScript USA Inc.
Рекомендации по теме
CD3ζ as a 1:02:52

CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors

CD3ζ as a 1:03:23

CD3ζ as a novel integration site for reprogramming immune cells with Chimeric Antigen Receptors

A new way 0:02:52

A new way of treating cancer by reprogramming our own immune cells with artificial protocells

GenScript 2nd Annual 0:00:39

GenScript 2nd Annual Gene & Cell Engineering Summit

Deciphering CAR-T Cells: 1:01:36

Deciphering CAR-T Cells: Exploring Functional Mechanisms to Drive Next Generation Immunotherapy

Combining JAK, PIM 0:03:41

Combining JAK, PIM kinase and CDK4/6 inhibition in MPNs

join shbcf.ru